Home 2020
Archives
COVID-19 at Forefront of IDWeek Discussions
IDWeek chairs Inger Damon, M.D., and Tom Talbot, M.D., discuss this year's annual meeting with HD Live!
AHA: CVD Risk Often Unaddressed for Transgender Population
Of those receiving gender-affirming hormone therapy, many have CV risk factors and are not receiving appropriate therapies
AHA: Young Adults With CVD Have Low Flu Vaccination Rates
Prevalence of flu vaccination lower among adults aged 18 to 34, 35 to 44 years with versus without history of MI
AHA: Remote Cardiac Rehab Is Effective Alternative to On-Site Programs
Two studies show no significant reduction in patient acceptance, adherence to virtual CR; remote CR as effective as outpatient CR
AHA: PTSD Tied to Ischemic Heart Disease in Female Veterans
Findings most pronounced in younger women and racial and ethnic minorities
Spinal Cord Stimulation May Ease Diabetic Nerve Pain
Early results of clinical trial show high rate of responders who achieved ≥50 percent pain relief
Dermatologic Manifestations of COVID-19 May Persist
Papulosquamous eruptions, pernio/chilblains last ≥60 days in some patients
In-Hospital Mortality Higher for Homeless Heart Attack Patients
Risk for death three times higher for homeless, despite receiving similar care
ASN: Finerenone May Slow Progression in CKD With T2DM
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Breast Cancer Surgery Feasible for Most Fit Older Women
Hormone therapy alone may be as good as surgery if life expectancy is less than four years
